{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for angiotensin root_names_stdName in Standardized Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2009)
Source URL:
First approved in 2009
Source:
Skinprint Acne Release by The Skin Atelier, Inc.
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
68 FR 32268 antigingivitis/plaque polydimethylsiloxane and poloxamer
Source URL:
First approved in 2009
Source:
M022
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NCT01416701: Phase 4 Interventional Withdrawn Chronic Obstructive Lung Disease
(2011)
Source URL:
First approved in 2008
Source:
Calcium Acetate 667 mg by Pharmin USA, LLC
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2007)
Source URL:
First approved in 2007
Source:
21 CFR 333A
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M012
(2024)
Source URL:
First approved in 2006
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA208643
(2006)
Source URL:
First approved in 2006
Source:
ANDA208643
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA065078
(2005)
Source URL:
First approved in 2005
Source:
ANDA065078
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 358H
(2009)
Source URL:
First approved in 2005
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2005)
Source URL:
First approved in 2005
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
68 FR 32268 antigingivitis/plaque polydimethylsiloxane and poloxamer
Source URL:
First approved in 2004
Source:
ANDA076523
Source URL:
Class:
POLYMER
